Brief: Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals
21/04/2025 13:02
April 21 (Reuters) - Aerovate Therapeutics Inc AVTE.O: AEROVATE THERAPEUTICS STOCKHOLDERS APPROVE PROPOSED MERGER WITH JADE BIOSCIENCES AND ALL RELATED PROPOSALS AEROVATE THERAPEUTICS INC - BOARD APPROVES 1-FOR-35 REVERSE STOCK SPLIT AEROVATE THERAPEUTICS INC - STOCKHOLDERS APPROVE MERGER WITH JADE BIOSCIENCES Source text: ID:nPn7b9tyJa Further company coverage: AVTE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million